Sanofi India Limited (SANOFI) — Board Meeting | 3 June 2026

StockFin.ai

Try Free

Sanofi India announced the appointment of Debajit Roy as Sales & Customer Engagement Head – Diabetes, effective 8 June 2026, following board approval on 3 June 2026. The role designates him as Senior Management Personnel, reflecting strategic focus on diabetes growth. Roy brings over 20 years of experience across key therapeutic areas, including recent leadership at Glenmark Pharmaceuticals.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SANOFI ✨ Ask AI About This

About Sanofi India Limited (SANOFI)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹7,411.02 Cr P/E: 17.9

View full SANOFI stock details →

📡 Get AI alerts when SANOFI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SANOFI — Free

💡 Ask AI about this filing

"How does this board meeting affect Sanofi India Limited's outlook?" "What did Sanofi India Limited announce on 3 June 2026?" "Is this positive or negative for SANOFI?"

Ask AI Free →

📊 More SANOFI filings

See all SANOFI filings →

🔥 Also filed on 3 June 2026

PRAJIND Praj Industries Limited Financial Results PRECOT Precot Limited Announcement PREMEXPLN Premier Explosives Limited Announcement PREMIERENE Premier Energies Limited Announcement PTCIL PTC Industries Limited Financial Results PRAJIND Praj Industries Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SANOFI files new disclosures

Track SANOFI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SANOFI — Free

Free account · 2 AI queries/day